Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide

Background: Glioblastoma (GBM) is a very poor-prognosis brain tumor. To date, maximal excision followed by radiochemotherapy, in 30 fractions, is the standard approach. Limited data are present in the literature about hypofractionated radiotherapy (hypo-RT) in GBM poor prognosis patients. Thus, this...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregucci, Fabiana, Surgo, Alessia, Bonaparte, Ilaria, Laera, Letizia, Ciliberti, Maria Paola, Carbonara, Roberta, Gentile, Maria Annunziata, Giraldi, David, Calbi, Roberto, Caliandro, Morena, Sasso, Nicola, D’Oria, Salvatore, Somma, Carlo, Martinelli, Gaetano, Surico, Giammarco, Lombardi, Giuseppe, Fiorentino, Alba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619413/
https://www.ncbi.nlm.nih.gov/pubmed/34834497
http://dx.doi.org/10.3390/jpm11111145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619413/
https://www.ncbi.nlm.nih.gov/pubmed/34834497
http://dx.doi.org/10.3390/jpm11111145

Ejemplares similares